REDWOOD SHORES, Calif., Feb. 01, 2017 -- Imperva, Inc. (NASDAQ:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, announced that the Imperva Incapsula solution is available in the Microsoft Azure Marketplace. Now customers can purchase the Incapsula service directly from the Marketplace and receive the benefits of one consolidated bill and unified contract management. Incapsula, along with the Imperva SecureSphere Web Application Firewall (WAF) and the SecureSphere Deployment Kit for Azure, make it even easier for customers to bring enterprise-grade application security to the cloud.
Already in use by Microsoft customers, Imperva Incapsula is a cloud-based application delivery service that helps protect websites and increases their performance, improving end user experiences and safeguarding web applications and data from attack. As more businesses move to the cloud, Incapsula is an ideal solution as it is suited to address both cloud and hybrid cloud requirements.
“We are pleased to roll out one of the first combination Cloud WAF and DDoS solutions to Microsoft Azure customers,” said Tim Matthews, vice president of marketing at Imperva. “Now, Azure customers can sign up for the Incapsula service directly through the Marketplace. This enables the Incapsula service to be deployed within minutes and to scale to any size of customer, which complements the ease-of-use of the Azure cloud platform and its diverse customer base.”
Ryan McGee, director, security product marketing, Microsoft Corp. said, “We are pleased to welcome the Incapsula solution to the Microsoft Azure Marketplace. It provides our mutual customers with the ability to migrate to the cloud and use the same world-class security solution that they use in their on-premises deployment to protect websites.”
For more information on Imperva Incapsula on Azure visit http://bit.ly/2i5d8Vs.
About Imperva
Imperva® (NASDAQ:IMPV) is a leading provider of cyber security solutions that protect business-critical data and applications. The company’s SecureSphere, CounterBreach, Incapsula and Skyfence product lines enable organizations to discover assets and risks, protect information wherever it lives -- in the cloud and on-premises -- and comply with regulations. The Imperva Defense Center, a research team comprised of some of the world’s leading experts in data and application security, continually enhances Imperva products with up-to-the-minute threat intelligence, and publishes reports that provide insight and guidance on the latest threats and how to mitigate them. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.
© 2017 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, CounterBreach, Incapsula, SecureSphere, Skyfence and ThreatRadar are trademarks of Imperva, Inc. and its subsidiaries.
EDITORIAL CONTACTS: Tami Casey Imperva [email protected] Lucy Harvey Eskenzi PR [email protected]


DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



